GB1219606A
(en)
|
1968-07-15 |
1971-01-20 |
Rech S Et D Applic Scient Soge |
Quinuclidinol derivatives and preparation thereof
|
LU88769I2
(fr)
|
1982-07-23 |
1996-11-05 |
Zeneca Ltd |
Bicalutamide et ses sels et esters pharmaceutiquement acceptables (Casodex (R))
|
US5093330A
(en)
|
1987-06-15 |
1992-03-03 |
Ciba-Geigy Corporation |
Staurosporine derivatives substituted at methylamino nitrogen
|
GB8916480D0
(en)
|
1989-07-19 |
1989-09-06 |
Glaxo Group Ltd |
Chemical process
|
GB8923590D0
(en)
|
1989-10-19 |
1989-12-06 |
Pfizer Ltd |
Antimuscarinic bronchodilators
|
US5395855A
(en)
|
1990-05-07 |
1995-03-07 |
Ciba-Geigy Corporation |
Hydrazones
|
PT100441A
(pt)
|
1991-05-02 |
1993-09-30 |
Smithkline Beecham Corp |
Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
|
US5451700A
(en)
|
1991-06-11 |
1995-09-19 |
Ciba-Geigy Corporation |
Amidino compounds, their manufacture and methods of treatment
|
NZ243082A
(en)
|
1991-06-28 |
1995-02-24 |
Ici Plc |
4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
|
AU661533B2
(en)
|
1992-01-20 |
1995-07-27 |
Astrazeneca Ab |
Quinazoline derivatives
|
WO1993019750A1
(en)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic or inflammatory diseases
|
US5552438A
(en)
|
1992-04-02 |
1996-09-03 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
DE69331265T2
(de)
|
1992-04-02 |
2002-08-08 |
Smithkline Beecham Corp |
Verbindungen zur behandlung von entzündlichen erkrankungen und zur hemmung der produktion von tumornekrosefaktor
|
TW225528B
(es)
|
1992-04-03 |
1994-06-21 |
Ciba Geigy Ag |
|
GB9301000D0
(en)
|
1993-01-20 |
1993-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
GB9314893D0
(en)
|
1993-07-19 |
1993-09-01 |
Zeneca Ltd |
Quinazoline derivatives
|
GB9414193D0
(en)
|
1994-07-14 |
1994-08-31 |
Glaxo Group Ltd |
Compounds
|
GB9414208D0
(en)
|
1994-07-14 |
1994-08-31 |
Glaxo Group Ltd |
Compounds
|
MX9707453A
(es)
|
1995-03-30 |
1997-12-31 |
Pfizer |
Derivados de quinazolina.
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
ES2172670T3
(es)
|
1995-07-06 |
2002-10-01 |
Novartis Ag |
Pirrolpirimidinas y procedimientos para su preparacion.
|
US5760041A
(en)
|
1996-02-05 |
1998-06-02 |
American Cyanamid Company |
4-aminoquinazoline EGFR Inhibitors
|
GB9603095D0
(en)
|
1996-02-14 |
1996-04-10 |
Zeneca Ltd |
Quinazoline derivatives
|
CA2249446C
(en)
|
1996-04-12 |
2008-06-17 |
Warner-Lambert Company |
Irreversible inhibitors of tyrosine kinases
|
JP2000512990A
(ja)
|
1996-06-24 |
2000-10-03 |
ファイザー・インク |
過増殖性疾患を処置するためのフェニルアミノ置換三環式誘導体
|
EP0954315A2
(en)
|
1996-09-13 |
1999-11-10 |
Sugen, Inc. |
Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
|
EP0837063A1
(en)
|
1996-10-17 |
1998-04-22 |
Pfizer Inc. |
4-Aminoquinazoline derivatives
|
GB9622386D0
(en)
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
TW528755B
(en)
|
1996-12-24 |
2003-04-21 |
Glaxo Group Ltd |
2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
|
CO4940418A1
(es)
|
1997-07-18 |
2000-07-24 |
Novartis Ag |
Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
|
US6166037A
(en)
|
1997-08-28 |
2000-12-26 |
Merck & Co., Inc. |
Pyrrolidine and piperidine modulators of chemokine receptor activity
|
AU9281298A
(en)
|
1997-10-01 |
1999-04-23 |
Kyowa Hakko Kogyo Co. Ltd. |
Benzodioxole derivatives
|
GB9721069D0
(en)
|
1997-10-03 |
1997-12-03 |
Pharmacia & Upjohn Spa |
Polymeric derivatives of camptothecin
|
GB9723590D0
(en)
|
1997-11-08 |
1998-01-07 |
Glaxo Group Ltd |
Chemical compounds
|
GB9723589D0
(en)
|
1997-11-08 |
1998-01-07 |
Glaxo Group Ltd |
Chemical compounds
|
GB9723566D0
(en)
|
1997-11-08 |
1998-01-07 |
Glaxo Group Ltd |
Chemical compounds
|
YU44900A
(sh)
|
1998-01-31 |
2003-01-31 |
Glaxo Group Limited |
Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
|
AR017457A1
(es)
|
1998-02-14 |
2001-09-05 |
Glaxo Group Ltd |
Compuestos derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol, procesos para su preparacion, composiciones que los contienen y su uso en terapia para el tratamiento de enfermedades inflamatorias.
|
AP2000002016A0
(en)
|
1998-06-23 |
2000-12-31 |
Glaxo Group Ltd |
2-(Purin-9-yl) Tetrahydrofuran-3,4-diol derivatives.
|
GB9813540D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
GB9813565D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
GB9813535D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
BR9815931A
(pt)
|
1998-06-30 |
2001-02-20 |
Dow Chemical Co |
Polióis poliméricos, um processo para sua produção, e espuma de poliuretanoobtida
|
JP3602445B2
(ja)
|
1998-10-16 |
2004-12-15 |
ファイザー・インク |
アデニン誘導体
|
GB9913083D0
(en)
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
RU2299206C9
(ru)
|
1999-05-04 |
2007-11-20 |
Шеринг Корпорейшн |
Производные пиперазина, фармацевтические композиции, их содержащие, и применение в качестве антагонистов ccr5
|
CN1151131C
(zh)
|
1999-05-04 |
2004-05-26 |
先灵公司 |
用作ccr5拮抗剂的哌啶衍生物
|
YU25500A
(sh)
|
1999-05-11 |
2003-08-29 |
Pfizer Products Inc. |
Postupak za sintezu analoga nukleozida
|
GB9913932D0
(en)
|
1999-06-15 |
1999-08-18 |
Pfizer Ltd |
Purine derivatives
|
US6322771B1
(en)
|
1999-06-18 |
2001-11-27 |
University Of Virginia Patent Foundation |
Induction of pharmacological stress with adenosine receptor agonists
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
IL147688A0
(en)
|
1999-08-21 |
2002-08-14 |
Byk Gulden Lomberg Chem Fab |
Synergistic combination
|
CO5180581A1
(es)
|
1999-09-30 |
2002-07-30 |
Pfizer Prod Inc |
Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
|
GB9924363D0
(en)
|
1999-10-14 |
1999-12-15 |
Pfizer Central Res |
Purine derivatives
|
GB9924361D0
(en)
|
1999-10-14 |
1999-12-15 |
Pfizer Ltd |
Purine derivatives
|
GB0003960D0
(en)
|
2000-02-18 |
2000-04-12 |
Pfizer Ltd |
Purine derivatives
|
TWI227240B
(en)
|
2000-06-06 |
2005-02-01 |
Pfizer |
2-aminocarbonyl-9H-purine derivatives
|
SI1300407T2
(sl)
|
2000-06-27 |
2011-09-30 |
S A L V A T Lab Sa |
Karbamati, izvedeni iz arilalkilaminov
|
GB0015727D0
(en)
|
2000-06-27 |
2000-08-16 |
Pfizer Ltd |
Purine derivatives
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
AR032361A1
(es)
|
2000-08-05 |
2003-11-05 |
Glaxo Group Ltd |
Derivados de androstano y sales y solvatos de los mismos, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que comprenden tales compuestos, proceso para la preparacion de dichos compuestos, e intermediarios utiles en la preparacion de tales compuestos
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
GB0022695D0
(en)
|
2000-09-15 |
2000-11-01 |
Pfizer Ltd |
Purine Derivatives
|
GB0028383D0
(en)
|
2000-11-21 |
2001-01-03 |
Novartis Ag |
Organic compounds
|
PE20020719A1
(es)
|
2000-12-22 |
2002-10-11 |
Almirall Prodesfarma Ag |
Derivados de carbamato de quinuclidina como agentes antimuscarinicos m3
|
JP4295985B2
(ja)
|
2000-12-28 |
2009-07-15 |
ラボラトリオス・アルミラル・ソシエダッド・アノニマ |
新規なキヌクリジン誘導体およびそれを含む医薬組成物
|
EP1241176A1
(en)
|
2001-03-16 |
2002-09-18 |
Pfizer Products Inc. |
Purine derivatives for the treatment of ischemia
|
HUP0400070A2
(hu)
|
2001-04-30 |
2004-04-28 |
Glaxo Group Limited |
17alfa-helyzetben ciklusos észtercsoportot tartalmazó androsztán-17béta-karbotiosav-észter-származékok mint gyulladásgátló szerek, eljárás a vegyületek előállítására és ezeket tartalmazó gyógyszerkészítmények
|
AR035885A1
(es)
|
2001-05-14 |
2004-07-21 |
Novartis Ag |
Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica
|
OA12609A
(en)
|
2001-05-25 |
2006-06-09 |
Pfizer |
An adenosine A2A receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases.
|
WO2002100879A1
(en)
|
2001-06-12 |
2002-12-19 |
Glaxo Group Limited |
Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
|
DK2327765T3
(en)
|
2001-06-21 |
2015-07-13 |
Basf Enzymes Llc |
nitrilases
|
GB0119249D0
(en)
|
2001-08-07 |
2001-10-03 |
Novartis Ag |
Organic compounds
|
IL160896A0
(en)
|
2001-10-17 |
2004-08-31 |
Ucb Sa |
Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
|
GB0125259D0
(en)
|
2001-10-20 |
2001-12-12 |
Glaxo Group Ltd |
Novel compounds
|
MY130622A
(en)
|
2001-11-05 |
2007-07-31 |
Novartis Ag |
Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
|
WO2003048181A1
(en)
|
2001-12-01 |
2003-06-12 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
IL162596A0
(en)
|
2001-12-20 |
2005-11-20 |
S A L V A T Lab Sa |
1-Alkyl-1-azoniabicyclo Ä2.2.2Ü octane carbamate derivatives and their use as muscarinic receptor ntagonists
|
AU2003202044A1
(en)
|
2002-01-15 |
2003-09-09 |
Glaxo Group Limited |
17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
|
WO2003062259A2
(en)
|
2002-01-21 |
2003-07-31 |
Glaxo Group Limited |
Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
|
GB0202216D0
(en)
|
2002-01-31 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
ES2298508T3
(es)
|
2002-03-26 |
2008-05-16 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Mimeticos de glucocorticoides, metodos para prepararlos, composiciones farmaceuticas y sus usos.
|
AU2003230700A1
(en)
|
2002-03-26 |
2003-10-13 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
ATE381336T1
(de)
|
2002-04-10 |
2008-01-15 |
Univ Virginia |
Verwendung von a2a adenosin rezeptor agonisten und anti-pathogene mittel enthaltenden kombinationen zur behandlung von entzündungskrankheiten
|
ES2206021B1
(es)
|
2002-04-16 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de pirrolidinio.
|
ES2201907B1
(es)
|
2002-05-29 |
2005-06-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
|
DE10224888A1
(de)
|
2002-06-05 |
2003-12-24 |
Merck Patent Gmbh |
Pyridazinderivate
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE10225574A1
(de)
|
2002-06-10 |
2003-12-18 |
Merck Patent Gmbh |
Aryloxime
|
DE10227269A1
(de)
|
2002-06-19 |
2004-01-08 |
Merck Patent Gmbh |
Thiazolderivate
|
WO2004000814A1
(en)
|
2002-06-25 |
2003-12-31 |
Merck Frosst Canada & Co. |
8-(biaryl) quinoline pde4 inhibitors
|
ES2204295B1
(es)
|
2002-07-02 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de quinuclidina-amida.
|
US20060004056A1
(en)
|
2002-07-02 |
2006-01-05 |
Bernard Cote |
Di-aryl-substituted-ethan pyridone pde4 inhibitors
|
JP4503436B2
(ja)
|
2002-07-08 |
2010-07-14 |
ファイザー・プロダクツ・インク |
糖質コルチコイド受容体のモジュレーター
|
PE20050130A1
(es)
|
2002-08-09 |
2005-03-29 |
Novartis Ag |
Compuestos organicos
|
JP2005538138A
(ja)
|
2002-08-10 |
2005-12-15 |
アルタナ ファルマ アクチエンゲゼルシャフト |
Pde4インヒビターとしてのピリダジノン誘導体
|
AU2003255376A1
(en)
|
2002-08-10 |
2004-03-11 |
Altana Pharma Ag |
Piperidine-derivatives as pde4 inhibitors
|
US20060166995A1
(en)
|
2002-08-10 |
2006-07-27 |
Altana Pharma Ag |
Piperidine-n-oxide-derivatives
|
WO2004018457A1
(en)
|
2002-08-10 |
2004-03-04 |
Altana Pharma Ag |
Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors
|
RS20050117A
(en)
|
2002-08-17 |
2007-06-04 |
Altana Pharma Ag., |
Novel benzonaphthyridines
|
US20060116518A1
(en)
|
2002-08-17 |
2006-06-01 |
Altana Pharma Ag |
Novel phenanthridines
|
SE0202483D0
(sv)
|
2002-08-21 |
2002-08-21 |
Astrazeneca Ab |
Chemical compounds
|
AU2002326072A1
(en)
|
2002-08-23 |
2004-03-11 |
Ranbaxy Laboratories Limited |
Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists
|
AU2003273805B8
(en)
|
2002-08-29 |
2010-06-17 |
Takeda Gmbh |
3-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
|
CA2495827C
(en)
|
2002-08-29 |
2012-05-08 |
Altana Pharma Ag |
2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
|
EP1541574A4
(en)
|
2002-09-18 |
2007-06-20 |
Ono Pharmaceutical Co |
TRIAZASPIRO DERIVATIVES 5.5 | UNDECANS AND DRUGS CONTAINING THEM AS AN ACTIVE INGREDIENT
|
JP2006096662A
(ja)
|
2002-09-18 |
2006-04-13 |
Sumitomo Pharmaceut Co Ltd |
新規6−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
JP2004107299A
(ja)
|
2002-09-20 |
2004-04-08 |
Japan Energy Corp |
新規1−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
DE10246374A1
(de)
|
2002-10-04 |
2004-04-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
CA2503015A1
(en)
|
2002-10-23 |
2004-05-06 |
Glenmark Pharmaceuticals Ltd. |
Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
DE10253220A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Dihydroxy-Methyl-Phenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
DE10253426B4
(de)
|
2002-11-15 |
2005-09-22 |
Elbion Ag |
Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
|
DE10253282A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
|
DK3034075T3
(en)
*
|
2006-11-22 |
2018-10-22 |
Incyte Holdings Corp |
IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASEI INHIBITORS
|
LT2300455T
(lt)
*
|
2008-05-21 |
2017-11-10 |
Incyte Holdings Corporation |
2-fluor-n-metil-4-[7-(chinolin-6-il-metil)-imidazo[1,2-b][1,2,4]triazin-2-il]benzamido druskos ir su jų gamyba susiję būdai
|
JP2012237586A
(ja)
*
|
2011-05-10 |
2012-12-06 |
Fujirebio Inc |
抗がん剤の効果的な治療方法を選択するための診断試薬
|
EP2834246B1
(en)
*
|
2012-04-03 |
2021-07-28 |
Novartis AG |
Combination products with tyrosine kinase inhibitors and their use
|
JOP20200097A1
(ar)
*
|
2013-01-15 |
2017-06-16 |
Aragon Pharmaceuticals Inc |
معدل مستقبل أندروجين واستخداماته
|